Ibuprofene Cristers Conseil (Ibuprofen Lysine)

Ibuprofen Lysine, an NSAID, acts on the prostaglandin pathway to provide symptomatic relief.

• Pain: reduces mild to moderate acute or chronic pain such as musculoskeletal or dental discomfort.
• Fever: lowers elevated body temperature associated with infectious or inflammatory processes.
• Inflammation: decreases swelling, redness, and heat in inflamed tissues.

• Ibuprofen Lysine exerts its effect by reversibly inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The reduction in prostaglandin synthesis diminishes peripheral sensitization of nociceptors, lowers the hypothalamic set‑point for temperature, and curtails inflammatory mediators, resulting in analgesic, antipyretic, and anti‑inflammatory actions.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort.
• Headache: mild to moderate intensity.
• Dizziness: transient sensation of light‑headedness.
• Rash: mild skin irritation or erythema.
• Diarrhoea: loose stools without blood.
• Elevated liver enzymes: transient increase in hepatic markers.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulcer perforation.
• Renal impairment or acute kidney injury.
• Severe allergic reactions such as anaphylaxis.
• Hepatic dysfunction with jaundice.
• Cardiovascular events including myocardial infarction or stroke.
• Blood dyscrasias: thrombocytopenia or neutropenia.

Before initiating therapy, consider patient‑specific risk factors and follow safe handling practices.

• Assess renal function: evaluate kidney status in patients with existing renal disease.
• Monitor gastrointestinal risk: avoid use in individuals with a history of peptic ulcer disease.
• Use lowest effective dose: limit duration to the shortest period necessary for symptom control.
• Avoid concomitant anticoagulants: increased risk of bleeding when combined with warfarin or similar agents.
• Contraindicated in hypersensitivity: do not use in patients allergic to ibuprofen or other NSAIDs.
• Store at room temperature: keep in the original packaging, protect from moisture and heat.

Ibuprofen Lysine can modify the pharmacodynamics or pharmacokinetics of several medicines; interaction severity varies.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): heightened bleeding risk.
• ACE inhibitors (e.g., enalapril): reduced antihypertensive effect and possible renal impairment.
• Lithium: increased serum lithium concentrations.
• Methotrexate: decreased clearance leading to toxicity.
• SSRIs (e.g., sertraline): additive risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely)

• Diuretics (e.g., furosemide): potential reduction in diuretic efficacy.
• Beta‑blockers (e.g., metoprolol): possible attenuation of blood‑pressure lowering effect.
• Corticosteroids (e.g., prednisone): increased risk of gastric ulceration.
• Antidiabetic agents (e.g., insulin): may affect glycaemic control.
• Allopurinol: possible increase in ibuprofen plasma levels.